Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.
about
From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized MedicineWhole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy: Implications for Sepsis Metabolomics.Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review.Emerging applications of metabolomics in drug discovery and precision medicine.Metabolic resuscitation in sepsis: a necessary step beyond the hemodynamic?Systematic Molecular Phenotyping: A Path Toward Precision Emergency Medicine?Metabolomics as a Driver in Advancing Precision Medicine in Sepsis.Generalizable Biomarkers in Critical Care: Toward Precision Medicine.The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.Emerging Biomarkers of Illness Severity: Urinary Metabolites Associated with Sepsis and Necrotizing Methicillin-Resistant Staphylococcus aureus Pneumonia.Septic Shock Non-Survivors have Persistently Elevated Acylcarnitines Following Carnitine Supplementation.Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism.Toxoplasma gondii GRA8 induces ATP5A1-SIRT3-mediated mitochondrial metabolic resuscitation: a potential therapy for sepsis.Vitamin C in the critically ill - indications and controversiesAssociation between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients
P2860
Q28067029-0A7E1901-7984-4B05-AB66-B0AB2DA30616Q35957668-23F4551B-E900-4AA4-AD8B-94D6DEC1619EQ38658253-A8B14E38-B47F-4083-B7CE-5B281EB8ABF7Q38769103-E86F3EB6-E7DF-46BD-B421-10989C21A199Q38833435-4F0EA26A-3467-48AD-B2B1-9E34347DDB5DQ38854820-D4C81415-68F8-4BA9-A2D0-CFB4F925EC66Q39386206-552668DF-0124-4786-9593-4EEC4CF81BA6Q40210673-BE298BD2-1D8B-42F4-99D3-C9F0910F69E4Q47662026-462A3F30-768A-4AFB-9D47-CCA2D8ADC852Q48249825-BE2D8168-4674-4C1A-804F-2DD5CA7F4E77Q49561103-2A9F3CE0-D0F5-4E7F-98B9-787482B2C7BFQ52677571-E8ED88E5-F638-4761-A3C3-3EE95CA98AC2Q54977017-38A6E25C-86C7-4328-A189-28C5A26BF659Q58121936-053823C9-A025-46A4-BCCE-86D9579E0E73Q58723478-5D14E340-CAD0-41FB-9119-1CE8E4705BDC
P2860
Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacometabolomics of l-carn ...... in patients with septic shock.
@ast
Pharmacometabolomics of l-carn ...... in patients with septic shock.
@en
type
label
Pharmacometabolomics of l-carn ...... in patients with septic shock.
@ast
Pharmacometabolomics of l-carn ...... in patients with septic shock.
@en
prefLabel
Pharmacometabolomics of l-carn ...... in patients with septic shock.
@ast
Pharmacometabolomics of l-carn ...... in patients with septic shock.
@en
P2093
P2860
P1476
Pharmacometabolomics of l-carn ...... in patients with septic shock
@en
P2093
Alan E Jones
Alla Karnovsky
Brooke N Harris
Julie Trexel
Kathleen A Stringer
Michael A Finkel
P2860
P356
10.1513/ANNALSATS.201409-415OC
P577
2015-01-01T00:00:00Z